The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / R•••••

S••••••• S•••••• Acquires R••••• on Focus, Expanding Strategic Capabilities to Drive Brand Success through Proprietary, Evidence-Based Approach to Positioning

Add-on acquisitionannouncedadd-onannouncement date unknownFact
What happened
Platform
S••••••• S••••••add-on basis: This is the third acquisition S••••••• has completed since its strategic partnership with K••• L••• in 2023. | published on K••• L•••'s own news page
Control
Control
Share acquired
unknown
Industry
consumer / brand
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • This is the third acquisition S••••••• has completed since its strategic partnership with K••• L••• in 2023. | published on K••• L•••'s own news page
  • This is the third acquisition S••••••• has completed since its strategic partnership with K••• L••• in 2023. | published on K••• L•••'s own news page
Side not stated
  • A•• H•••••Managementconfirmed
    “The acquisition of R••••• on Focus is a natural extension of S•••••••’s commitment to delivering unmatched strategic value to our clients,” said A•• H•••••, President and Chief Commercial Officer of S••••••• S••••••.
  • “At S•••••••, we’ve found an ideal collaborator in an organization that shares our commitment to applying scientific and strategic acumen to optimize our client’s commercial success,” said D•• R••••••••, President of R••••• on Focus.
  • R•••••Targetconfirmed
    S••••••• S••••••, an independent, full-service, strategic platform offering integrated healthcare marketing communications, clinical trial recruitment and retention, advertising, consulting and media services today announced the acquisition of R••••• on Focus, a strategic marketing organization that
Evidence
S••••••• S••••••, an independent, full-service, strategic platform offering integrated healthcare marketing communications, clinical trial recruitment and retention, advertising, consulting and media services today announced the acquisition of R••••• on Focus, a strategic marketing organization that helps pharmaceutical and biotech companies create value for their brands through a proprietary, evidence-based approach to positioning and other foundational strategic services.
S••••••• S•••••• Acquires R••••• on Focus, Expanding Strategic Capabilities to Drive Brand | Private Equity Intelligence | DFX